Also on this list
Oak
Its headline price needs a 12-month plan — and no pharmacy is named anywhere.
Another provider on our tesamorelin provider ranking.
Read the Oak review →Provider review
Neuvé MD lists sermorelin at $249/mo (advertised as $229 first month), tirzepatide at $349/mo (advertised as $299 first month) and semaglutide at $219/mo (advertised as $189 first month), plus 4 more below. Prices checked October 2026.
Monthly prices that include the drug — after a cheaper first month.
Semaglutide is $219 a month and tirzepatide $349 at a standard dose, each with a lower first month. Medication, consult, shipping and supplies are included; labs are extra.
Transparency scorecard
2 of 4 disclosed openly
What Neuvé MD discloses about itself, read from its own pages — not estimated.
Pharmacy category stated
Not disclosed
States no federal regulatory category (503A/503B) for its pharmacy on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. A commission does not change what a review says. Full disclosure here.
At a glance
Visit Neuvé MDPharmacy
Not categorized
Labs
Charged separately when required, through its own lab…
States
All 50 states
Also on this list
Oak
Its headline price needs a 12-month plan — and no pharmacy is named anywhere.
Another provider on our tesamorelin provider ranking.
Read the Oak review →| Compound | Advertised | What you pay monthly | Pharmacy | Checked |
|---|---|---|---|---|
| Sermorelin | $229 first month | $249/moHigher than advertised | Not disclosed | October 2026 |
| Tirzepatide | $299 first month | $349/moHigher than advertised | Not disclosed | October 2026 |
| Semaglutide | $189 first month | $219/moHigher than advertised | Not disclosed | October 2026 |
| NAD+ | $169 first month | $199/moHigher than advertised | Not disclosed | October 2026 |
| Glutathione | $169 first month | $199/moHigher than advertised | Not disclosed | October 2026 |
| GHK-Cu | $189 first month | $219/moHigher than advertised | Not disclosed | October 2026 |
| Tesamorelin | From $299/mo | From $299/mo | Not disclosed | October 2026 |
What this price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not confirmed
Coaching
Not confirmed
The catch — The first number on most cards is a first month, not the rate: semaglutide reads "First month $189" above $219, tirzepatide "First month $299" above $349, and the same pattern runs through its peptides. Its weight-loss page shows only the standing prices, and labs are extra — the $45 GLP-1 panel is labeled an "optional add-on" in the same box that says it is "Required within 90 days of starting, then annually".
See plans at Neuvé MDPrices read from Neuvé MD's own site
What they advertise
"WEIGHT LOSS from $179 /month" on its pricing page, then per-product cards: semaglutide injectable $219/month ("First month $189"), microdose $179 (first month $149), oral RDT $329; tirzepatide injectable $349 (first month $299), microdose $240 (first month $199), oral RDT $279.
What you actually pay
$219/mo for compounded semaglutide and $349/mo for tirzepatide at a standard injectable dose, after a first month at $189 and $299. Microdose plans are $179 and $240, daily oral tablets $329 and $279. Sermorelin is $249, NAD+ and glutathione injections $199, GHK-Cu injection $219, and tesamorelin "$299 /month · starting at". Each price includes medication when prescribed, the clinician consult, shipping and injection supplies.
Money you will meet later
Neuvé MD — Neuve Health, LLC, of Gilbert, Arizona — publishes one of the fullest price menus on this site, every product and lab panel visible without an account. Compounded semaglutide is $219 a month at a standard dose ($179 as a microdose, $329 as a daily oral tablet) and tirzepatide $349 ($240 microdose, $279 oral), with sermorelin, NAD+, glutathione, GHK-Cu and tesamorelin on the same menu. Its pricing, weight-loss and billing pages agree that the plan price includes the medication, the clinician consult, shipping and injection supplies, with labs charged separately. The catches: most prices are preceded by a cheaper first month, its policies are labeled draft copy "being reviewed by counsel", and no clinician or pharmacy is named.
Neuvé MD appears on our sermorelin provider ranking, our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking, our Glutathione provider ranking, our GHK-Cu provider ranking, our tesamorelin provider ranking and our combined weight loss injections ranking.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Neuvé MD states no 503A/503B category for the pharmacy that fills your prescription.
No pharmacy is named, and no compounding category is stated: its pages say only that medication is "prepared by a licensed fulfillment facility" and "dispensed by vetted US pharmacy partners", shipped from "US-licensed fulfillment facilities". No facility, license number or NPI. No clinician is named either — its homepage says "Board-certified MD" and "U.S. MDs", and its provider page is a recruiting page whose quotes carry specialties but no names.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
All 50 states, per its homepage FAQ ("Care available in all 50 states") and a "50 STATES LICENSED" counter, with eligibility checked by a state picker at sign-up. Its Terms add that availability varies by state, service and provider.
The part they would rather you skipped
Neuvé MD's headline prices are first months. Its pricing page leads each card with a lower figure — "First month $189" over a $219 semaglutide plan, "First month $299" over $349 tirzepatide — and its weight-loss page shows only the standing price, so the two pages read differently at a glance. Labs sit outside the price, and its $45 GLP-1 panel is called an "optional add-on" in the same box that says it is required within 90 days and then every year. Beyond the prices: every policy page it publishes — Terms, refund, billing — ends by saying it is "plain-English summary copy" still "being reviewed by counsel" and "may be updated before public launch", and the site names no clinician and no pharmacy anywhere while its homepage promises a "Board-certified MD".
Other providers on our tesamorelin provider ranking — the closest match to what Neuvé MD sells.



A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Ready to get started?
Prices and plans in this category change often — check Neuvé MD's current pricing before you decide. Ours was read from their own site.
Facts on this page reflect Neuvé MD's own public disclosures when we last checked them. Prices and terms change without notice — confirm on Neuvé MD's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.
Neuvé MD
7 compounds from $199/mo